Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Elizabeth Plimack is an Oncologist in Philadelphia, Pennsylvania. Plimack has been practicing medicine for over 21 years and is rated as an Elite expert by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 13 other conditions, according to our data. Her top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, and Orchiectomy. Plimack is currently accepting new patients.
Gary Steinberg is an Urologist in New York, New York. Steinberg has been practicing medicine for over 38 years and is rated as an Elite expert by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Endoscopy. Steinberg is currently accepting new patients.
Ashish Kamat is an Urologist in Houston, Texas. Kamat has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Endoscopy. Kamat is currently accepting new patients.
Summary: This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as gemcitabine, cisplatin, fluorouracil and mitomycin-C, work in different ways to stop the growth of cancer cells, eithe...
Summary: Subjects with cT2-T3N0M0 urothelial cancer of the bladder will be enrolled. After completing two cycles of pembrolizumab, subjects will undergo a restaging MRI of the abdomen and pelvis with a standard acquisition protocol (as outlined in the protocol) as well as CT chest. A CT of the abdomen and pelvis may be performed if there are contraindications to MRI. Patients will also undergo a restaging ...